A detailed history of Balyasny Asset Management LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 24,100 shares of BSX stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,100
Previous 21,100 14.22%
Holding current value
$2.17 Million
Previous $1.62 Million 24.32%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $39.4 Million - $45.3 Million
539,531 Added 18.5%
3,455,604 $290 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $89.1 Million - $103 Million
1,322,739 Added 83.02%
2,916,073 $225 Million
Q1 2024

May 13, 2024

BUY
$57.6 - $68.62 $15 Million - $17.9 Million
260,778 Added 19.57%
1,593,334 $109 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $64.4 Million - $76.6 Million
1,324,980 Added 17489.18%
1,332,556 $77 Million
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $568,953 - $619,852
-11,336 Reduced 59.94%
7,576 $400,000
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $28.6 Million - $31.4 Million
-575,106 Reduced 96.82%
18,912 $1.02 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $26.8 Million - $29.7 Million
594,018 New
594,018 $29.7 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $42.7 Million - $128 Million
1,163,565 Added 98.29%
2,347,335 $90.9 Million
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $24.9 Million - $33.3 Million
707,487 Added 148.54%
1,183,770 $44.1 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $19.5 Million - $21.5 Million
476,283 New
476,283 $21.1 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $82.1 Million - $96.7 Million
-2,155,328 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $17.5 Million - $19.4 Million
423,352 Added 24.44%
2,155,328 $93.5 Million
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $61.1 Million - $70.1 Million
1,583,798 Added 1068.85%
1,731,976 $74.1 Million
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $61.3 Million - $79.5 Million
-2,031,758 Reduced 93.2%
148,178 $5.2 Million
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $47.9 Million - $84.7 Million
1,853,465 Added 567.73%
2,179,936 $71.1 Million
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $12.4 Million - $14.8 Million
326,471 New
326,471 $14.8 Million
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $21.5 Million - $26.5 Million
-616,675 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $20.3 Million - $25.1 Million
616,675 New
616,675 $23.7 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $14.9 Million - $18.3 Million
-468,618 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $10.8 Million - $12.7 Million
-327,892 Reduced 41.17%
468,618 $18 Million
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $17.9 Million - $22.9 Million
668,139 Added 520.48%
796,510 $26 Million
Q1 2018

May 15, 2018

SELL
$25.2 - $28.54 $20.4 Million - $23.1 Million
-808,738 Reduced 86.3%
128,371 $3.51 Million
Q4 2017

Feb 14, 2018

SELL
$24.79 - $29.8 $1.11 Million - $1.34 Million
-44,815 Reduced 4.56%
937,109 $23.2 Million
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $25.8 Million - $28.6 Million
981,924
981,924 $28.6 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.